Accelerated nodulosis and vasculitis following etanercept therapy for rheumatoid arthritis
- 12 August 2002
- journal article
- case report
- Published by Wiley in Arthritis Care & Research
- Vol. 47 (4) , 445-449
- https://doi.org/10.1002/art.10535
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Infliximab and Methotrexate in the Treatment of Rheumatoid ArthritisNew England Journal of Medicine, 2000
- A Comparison of Etanercept and Methotrexate in Patients with Early Rheumatoid ArthritisNew England Journal of Medicine, 2000
- Assessment of antibodies to double-stranded DNA induced in rheumatoid arthritis patients following treatment with infliximab, a monoclonal antibody to tumor necrosis factor α: Findings in open-label and randomized placebo-controlled trialsArthritis & Rheumatism, 2000
- Development of diabetes mellitus during etanercept therapy in a child with systemic-onset juvenile rheumatoid arthritisArthritis & Rheumatism, 2000
- Reduction of chemokine levels and leukocyte traffic to joints by tumor necrosis factor α blockade in patients with rheumatoid arthritisArthritis & Rheumatism, 2000
- Role of tumour necrosis factor α in experimental arthritis: separate activity of interleukin 1β in chronicity and cartilage destructionAnnals of the Rheumatic Diseases, 1999
- Treatment of Rheumatoid Arthritis with a Recombinant Human Tumor Necrosis Factor Receptor (p75)–Fc Fusion ProteinNew England Journal of Medicine, 1997
- Decrease in cellularity and expression of adhesion molecules by anti–tumor necrosis factor α monoclonal antibody treatment in patients with rheumatoid arthritisArthritis & Rheumatism, 1996
- Palisading cells of rheumatoid nodules: comparison with synovial intimal cells.Annals of the Rheumatic Diseases, 1993
- Increased levels of soluble tumor necrosis factor receptors in the sera and synovial fluid of patients with rheumatic diseasesArthritis & Rheumatism, 1992